Switching from Tacrolimus to Sirolimus Halts the Appearance of New Sebaceous Neoplasmsin Muir-Torre Syndrome

This publication has 24 references indexed in Scilit:

• The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
  Cancer Cell, 2006
• Cancer incidence after immunosuppressive treatment following kidney transplantation
  Critical Reviews in Oncology/Hematology, 2005
• Cancer after Kidney Transplantation in the United States
  American Journal of Transplantation, 2004
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
  Nature Reviews Cancer, 2002
• An Association Between Sebaceous Carcinoma and Microsatellite Instability in Immunosuppressed Organ Transplant Recipients
  Journal of Investigative Dermatology, 2001
• Muir-Torré syndrome in a patient with acquired immunodeficiency syndrome
  British Journal of Dermatology, 1996
• Structure of the Human MSH2 Locus and Analysis of Two Muir-Torre Kindreds for msh2 Mutations
  Genomics, 1994
• Sebaceous adenoma in a patient with acquired immunodeficiency syndrome
  Archives of Dermatology, 1988
• Torre's syndrome: Exacerbation of cutaneous manifestations with immunosuppression
  Journal of the American Academy of Dermatology, 1986
• The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome
  Archives of internal medicine (1960), 1981